These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8742150)

  • 21. American Academy of Pediatrics Committee on Infectious Diseases: Haemophilus influenzae type b conjugate vaccines: recommendations for immunization with recently and previously licensed vaccines.
    Pediatrics; 1993 Sep; 92(3):480-8. PubMed ID: 8361814
    [No Abstract]   [Full Text] [Related]  

  • 22. Cost-benefit analysis of two strategies for prevention of Haemophilus influenzae type b infection.
    Hay JW; Daum RS
    Pediatrics; 1987 Sep; 80(3):319-29. PubMed ID: 3114708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conjugated Haemophilus influenzae type b vaccine.
    Med Lett Drugs Ther; 1988 Apr; 30(764):47-8. PubMed ID: 3258400
    [No Abstract]   [Full Text] [Related]  

  • 24. Polysaccharide vaccine for prevention of Haemophilus influenzae type b disease.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Apr; 34(15):201-5. PubMed ID: 3920487
    [No Abstract]   [Full Text] [Related]  

  • 25. [Anti-hepatitis B and anti-Haemophilus influenzae type b vaccines].
    Dias PG
    Acta Med Port; 1997; 10(2-3):129-38. PubMed ID: 9235843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is Hemophilus influenzae type b disease preventable?
    Ward JI
    JAMA; 1985 Jan; 253(4):554-6. PubMed ID: 3918183
    [No Abstract]   [Full Text] [Related]  

  • 27. Haemophilus influenzae type B vaccine in children with sickle cell disease: antibody persistence after vaccination at age one and one-half to six years.
    Marcinak JF; Frank AL; Labotka RL; Rao S; Frisone LR; Yogev R; McVerry P
    Pediatr Infect Dis J; 1991 Feb; 10(2):157-9. PubMed ID: 2062609
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunization of US children with Hemophilus influenzae type b polysaccharide vaccine. A cost-effectiveness model of strategy assessment.
    Cochi SL; Broome CV; Hightower AW
    JAMA; 1985 Jan; 253(4):521-9. PubMed ID: 3918181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. National Advisory Committee on Immunization (NACI). Statement on Haemophilus influenzae type B conjugate vaccines for use in infants and children.
    Can Commun Dis Rep; 1992 Dec; 18(23):169-76. PubMed ID: 1291012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology and immunology of Hemophilus influenzae type B infections in childhood: implications for chemoprophylaxis and immunization.
    Hetherington S; Lepow ML
    Adv Pediatr Infect Dis; 1987; 2():1-18. PubMed ID: 3331279
    [No Abstract]   [Full Text] [Related]  

  • 31. [Conjugated vaccines against Haemophilus influenzae type b].
    Bustos G
    Aten Primaria; 1995 Jun; 16(2):65-6. PubMed ID: 7626733
    [No Abstract]   [Full Text] [Related]  

  • 32. [Surveillance of Haemophilus influenzae serotypes in Argentina from 2005 to 2010 during the Haemophilus influenzae type b conjugate vaccine era].
    Efron AM; Moscoloni MA; Reijtman VR; Regueira M
    Rev Argent Microbiol; 2013; 45(4):240-7. PubMed ID: 24401777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Invasive Disease Caused by Nontypeable Haemophilus influenzae.
    Langereis JD; de Jonge MI
    Emerg Infect Dis; 2015 Oct; 21(10):1711-8. PubMed ID: 26407156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic diversity of invasive strains of Haemophilus influenzae type b before and after introduction of the conjugate vaccine in Italy.
    Cerquetti M; Cardines R; Giufrè M; Sofia T; D'Ambrosio F; Mastrantonio P; Ciofi degli Atti ML
    Clin Infect Dis; 2006 Aug; 43(3):317-9. PubMed ID: 16804847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infections due to Haemophilus influenzae serotype E: microbiological, clinical, and epidemiological features.
    Campos J; Román F; Pérez-Vázquez M; Oteo J; Aracil B; Cercenado E;
    Clin Infect Dis; 2003 Sep; 37(6):841-5. PubMed ID: 12955648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do we need a booster of Hib vaccine after primary vaccination? A study on anti-Hib seroprevalence in Sweden 5 and 15 years after the introduction of universal Hib vaccination related to notifications of invasive disease.
    Hallander HO; Lepp T; Ljungman M; Netterlid E; Andersson M
    APMIS; 2010 Nov; 118(11):878-87. PubMed ID: 20955461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hib immunisation catch up programme in North East Thames.
    O'Brien H
    Commun Dis Rep CDR Rev; 1994 Feb; 4(2):R17-8. PubMed ID: 7511460
    [No Abstract]   [Full Text] [Related]  

  • 38. FDA approval of use of a new Haemophilus b conjugate vaccine and a combined diphtheria-tetanus-pertussis and Haemophilus b conjugate vaccine for infants and children.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1993 Apr; 42(15):296-8. PubMed ID: 8479415
    [No Abstract]   [Full Text] [Related]  

  • 39. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB): clinical evaluation.
    Ahonkhai VI; Lukacs LJ; Jonas LC; Matthews H; Vella PP; Ellis RW; Staub JM; Dolan KT; Rusk CM; Calandra GB
    Pediatrics; 1990 Apr; 85(4 Pt 2):676-81. PubMed ID: 2107518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Haemophilus vaccines. Their importance in tropical pediatrics].
    Bégué P
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):912-6. PubMed ID: 1819437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.